01 1Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
01 1ACARBOSE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-06-07
Pay. Date : 2021-03-17
DMF Number : 35188
Submission : 2020-10-30
Status : Active
Type : II
20
Livzon Group Fuzhou Fuxing Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ACARBOSE, with a corresponding US DMF Number 35188.
Remarkably, this DMF maintains an Active status since its submission on October 30, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 07, 2021, and payment made on March 17, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
